BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 112 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $129,792 | +80.4% | 25,600 | 0.0% | 0.00% | – |
| Q4 2023 | $71,936 | +39.2% | 25,600 | +42.2% | 0.00% | – |
| Q3 2023 | $51,660 | – | 18,000 | +149900.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 12 | -100.0% | 0.00% | – |
| Q4 2021 | $205,000 | -52.0% | 38,518 | -23.9% | 0.00% | – |
| Q3 2021 | $427,000 | +89.8% | 50,586 | +444.3% | 0.00% | – |
| Q1 2021 | $225,000 | -70.5% | 9,293 | -61.0% | 0.00% | – |
| Q4 2020 | $763,000 | – | 23,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $5,581,000 | 0.29% |
| NEA Management Company, LLC | 3,449,845 | $9,556,000 | 0.28% |
| Hawkeye Capital Management, LLC | 243,009 | $673,000 | 0.26% |
| DAFNA Capital Management LLC | 313,600 | $869,000 | 0.23% |
| Artal Group S.A. | 1,646,517 | $4,561,000 | 0.19% |
| MPM BioImpact LLC | 239,888 | $664,000 | 0.18% |
| RA Capital Management | 2,589,904 | $7,174,000 | 0.16% |
| Bellevue Group AG | 3,293,000 | $9,122,000 | 0.11% |
| Ikarian Capital, LLC | 159,390 | $441,000 | 0.06% |
| PDT Partners, LLC | 66,168 | $183,000 | 0.02% |